• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
White knockout Marengo logo
  • About
  • Science
  • Pipeline
  • START-001
  • START-002
  • News & Investors
  • Join Us
  • Contact Us
Back to news
10/02/2026
Press releases

Interim Phase 2 Results from First-in-Class Combination of Invikafusp Alfa and TRODELVY® Selected for Oral Presentation at SITC 2026

White knockout Marengo logo
Marengo Therapeutics, Inc.
840 Memorial Drive, 4th Floor
Cambridge, MA 02139
info@marengotx.com
X logo LinkedIn logo
Terms of Use Privacy Policy
© Marengo Therapeutics, Inc.
All Rights Reserved.
Great Place to Work logo Great Place to Work logo
Apple Tree Partners
ATP IS DEVELOPING THE NEXT GENERATION OF
TRANSFORMATIVE LIFE SCIENCES COMPANIES.